Roundtable Discussion: TAVR in Low-Risk Patients
Experts discuss the significance of recent data and the potential impact on their practice.
With Kentaro Hayashida, MD, PhD, FESC, FACC, FJCS; Robert Ostfeld, MD, MSc, FACC; Bernard Prendergast, BMedSci, BM BS, MRCP, DM, FRCP, FESC; Michael J. Reardon, MD; and Steven J. Yakubov, MD, FACC, FSCAI
